Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Friedman

Showing results (1381-1390 of 1,475) with videos related to

Pageof 148
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Expert-augmented machine learningEfstathios D Gennatas, Jerome H Friedman, Lyle H Ungar, et al.
Journal of Clinical Neuromuscular Disease|December 17, 2008
Clinical Studies in Non-chromosome 4-Linked Facioscapulohumeral Muscular DystrophyR W Tim, J R Gilbert, J M Stajich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Exercise behavior, functional capacity, and survival in adults with malignant recurrent gliomaEmily Ruden, David A Reardon, April D Coan, et al.
Pacing and Clinical Electrophysiology : PACE|January 11, 2003
Pacemaker therapy in isolated congenital complete atrioventricular blockJohannes M P J Breur, Floris E A Udink Ten Cate, Livia Kapusta, et al.
Neuro-Oncology|March 25, 2008
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant gliomaDavid A Reardon, Annick Desjardins, James J Vredenburgh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastomaDavid A Reardon, Scott Turner, Katherine B Peters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work groupBernard Ravina, Karen Marder, Hubert H Fernandez, et al.
Neuro-Oncology|March 18, 2009
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiformeJennifer A Quinn, Sara Xiaoyin Jiang, James Carter, et al.
Pageof 148

Showing results (1381-1390 of 1,475) with videos related to

Sort By:
Pageof 148
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Expert-augmented machine learningEfstathios D Gennatas, Jerome H Friedman, Lyle H Ungar, et al.
Journal of Clinical Neuromuscular Disease|December 17, 2008
Clinical Studies in Non-chromosome 4-Linked Facioscapulohumeral Muscular DystrophyR W Tim, J R Gilbert, J M Stajich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Exercise behavior, functional capacity, and survival in adults with malignant recurrent gliomaEmily Ruden, David A Reardon, April D Coan, et al.
Pacing and Clinical Electrophysiology : PACE|January 11, 2003
Pacemaker therapy in isolated congenital complete atrioventricular blockJohannes M P J Breur, Floris E A Udink Ten Cate, Livia Kapusta, et al.
Neuro-Oncology|March 25, 2008
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant gliomaDavid A Reardon, Annick Desjardins, James J Vredenburgh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastomaDavid A Reardon, Scott Turner, Katherine B Peters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work groupBernard Ravina, Karen Marder, Hubert H Fernandez, et al.
Neuro-Oncology|March 18, 2009
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiformeJennifer A Quinn, Sara Xiaoyin Jiang, James Carter, et al.
Pageof 148